Cargando…
Oral Dextromethorphan for the Treatment of Diabetic Macular Edema: Results From a Phase I/II Clinical Study
PURPOSE: The activation of microglia, the primary innate immune cell resident in the retina, produces inflammatory mediators, which underlie changes in diabetic retinopathy including increased vascular permeability. This study evaluates the safety and efficacy of dextromethorphan, a drug capable of...
Autores principales: | Valent, David J., Wong, Wai T., Chew, Emily Y., Cukras, Catherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300336/ https://www.ncbi.nlm.nih.gov/pubmed/30584490 http://dx.doi.org/10.1167/tvst.7.6.24 |
Ejemplares similares
-
Macular Thickness in Intermediate Age-Related Macular Degeneration Is Influenced by Disease Severity and Subretinal Drusenoid Deposit Presence
por: Chiang, Trent Tsun-Kang, et al.
Publicado: (2020) -
Repeatability of Scotopic Sensitivity and Dark Adaptation Using a Medmont Dark-Adapted Chromatic Perimeter in Age-related Macular Degeneration
por: Uddin, Durin, et al.
Publicado: (2020) -
Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments
por: Sun, Jennifer K., et al.
Publicado: (2021) -
Diabetic Macular Edema
por: Gundogan, Fatih C., et al.
Publicado: (2016) -
Advances in retinal imaging for diabetic retinopathy and diabetic macular edema
por: Tan, Colin Siang Hui, et al.
Publicado: (2016)